SYNthesis med chem opens new medicinal chemistry unit in Cambridge's Babraham Research Campus

SYNthesis med chem, the global contract research organisation providing synthetic and medicinal chemistry services, today announced that the company has opened a new facility at the Babraham Research Campus in Cambridge, UK. 

SYNthesis operates a unique business model, combining medicinal chemistry expertise located at the company's labs in Melbourne, Australia and now Cambridge, UK with flexible, high quality, cost effective synthetic chemistry expertise provided by the company's synthetic chemists based in Shanghai, China. The opening of this new facility in Cambridge, UK has enabled SYNthesis to add UK-based medicinal chemistry expertise to the organisation and to provide European customers with local project management for all synthetic and medicinal chemistry projects.

Professor Andrew Wilks, co-founder and Executive Chairman of SYNthesis, commented:

“With an increasing customer base across Europe it was essential that we put in place the infrastructure and resources to deliver the required levels of support for all our medicinal and synthetic chemistry projects. The new Cambridge facility does that, but also gives us the capacity to grow as we attract new customers.”

Dr Xian Bu, co-founder and Managing Director of SYNthesis commented: 

“Our “best of both worlds” approach has worked well for SYNthesis over the past six years. It has enabled us to expand our total global chemistry capacity to over 60 chemists and the opening of this new facility in the UK will allow us to take the next step forward. In addition to establishing this new office and labs in Cambridge UK we will be announcing plans for our operations in China later this year.”

Derek Jones of the Babraham Research Campus in Babraham Cambridge UK commented:

“We are delighted that SYNthesis med chem has chosen the Babraham Research Campus as the home for their European operations and we welcome them here at the heart of the Cambridge bio-medical cluster. I am sure that with access to the facilities, resources and community we have on the Babraham Research Campus, and a supportive and entrepreneurial environment in the wider Cambridge region will help ensure that SYNthesis grows and develops their operations successfully.”